Last10K.com

Accelrys, Inc. (ACCL) SEC Filing 10-Q Quarterly report for the period ending Sunday, September 30, 2012

Accelrys, Inc.

CIK: 1002388 Ticker: ACCL


Exhibit 99.1
ACCELRYS ANNOUNCES THIRD QUARTER RESULTS
Non-GAAP Revenue up 14% to $43.4 million

San Diego, October 31, 2012
- Accelrys, Inc. (NASDAQ: ACCL) today reported financial results for the fiscal quarter ended September 30, 2012, including a 14% year-over-year increase in Non-GAAP revenue.
Non-GAAP revenue for the quarter ended September 30, 2012 increased $5.4 million to $43.4 million from $38.0 million for the same quarter of the previous year, or an increase of 14%. Non-GAAP revenue for the nine months ended September 30, 2012, increased $12.6 million to $126.8 million from $114.1 million for the same period of the previous year, or an increase of 11%.
Non-GAAP net income was $6.3 million, or $0.11 per diluted share, for the quarter ended September 30, 2012 compared to non-GAAP net income of $5.4 million, or $0.10 per diluted share, for the same quarter of the previous year. Non-GAAP net income was $15.1 million, or $0.27 per diluted share, for the nine months ended September 30, 2012 compared to non-GAAP net income of $14.5 million, or $0.26 per diluted share, for the same period of the previous year.
GAAP revenue for the quarter ended September 30, 2012 increased $4.2 million to $40.5 million from $36.3 million for the same quarter of the previous year, or an increase of 12%. GAAP revenue for the nine months ended September 30, 2012 increased $13.8 million to $118.3 million from $104.6 million for the same period of the previous year, or an increase of 13%.
GAAP net income was $0.6 million, or $0.01 per diluted share, for the current quarter compared to GAAP net loss of $(2.2) million, or $(0.04) per diluted share, for the same quarter of the previous year. GAAP net loss was $(2.2) million, or $(0.04) per diluted share, for the nine months ended September 30, 2012 compared to GAAP net loss of $(12.4) million, or $(0.22) per diluted share, for the same period of the previous year.
“We delivered excellent results again this quarter, including double digit revenue growth for the second quarter in a row,” said Max Carnecchia, President & CEO of Accelrys.  “We also just concluded the acquisition of Aegis Analytical Corporation, thereby continuing to execute on our strategy of extending our portfolio from early research downstream into development, quality and manufacturing.  I am pleased to welcome the Aegis team to Accelrys and look forward to the strategic value we will bring to our customers through this combination.”

Recent Business Highlights:

Announced the acquisition of Aegis Analytical Corporation, expanding Accelrys' portfolio with industry-leading enterprise process intelligence capabilities.  Aegis software will be become part of the Accelrys Process Management and Compliance suite, providing organizations with unmatched insights into their product development, quality and manufacturing processes.

Announced the new integrated Accelrys Process Management and Compliance Suite, improving the way businesses manage the scientific innovation lifecycle by bringing products to market faster and at a lower cost, while meeting critical quality and regulatory compliance objectives.

Announced the latest release of Accelrys Electronic Laboratory Notebook (formerly Symyx Notebook by Accelrys), offering new capabilities that deliver a more complete biology solution for the fastest growing area of drug discovery and development.

Non-GAAP results for the three and nine months ended September 30, 2012 exclude the impact of business combination activities associated with the acquisitions of Contur Industry Holding AB and Contur Software AB (collectively, “Contur”) and VelQuest Corporation (“VelQuest”), both in 2011, and the merger with Symyx Technologies, Inc. (“Symyx”) in 2010, and other nonrecurring items.
Non-GAAP revenue, non-GAAP operating loss, and non-GAAP net income for the three and nine months ended September 30, 2012 include fair value adjustments to deferred revenue ($2.9 million and $8.4 million, respectively). Non-GAAP operating income for such three and nine-month periods also excludes stock-based compensation expense ($2.0 million and $5.6 million, respectively), business consolidation, transaction and restructuring costs ($0.7 million and $1.3 million, respectively) and purchased intangible asset amortization ($4.2 million and $12.6 million, respectively), offset by an adjustment to include acquisition-related cost of revenue related to VelQuest non-GAAP revenue recognized during such periods ($0.5 million and $1.2 million, respectively). In addition to the aforementioned items, non-GAAP net income for the same periods includes fair value adjustments to deferred royalty income ($0.2 million and $0.6 million, respectively) and excludes additional purchased intangible asset amortization ($0.4 million and $1.3 million, respectively) offset by removing the impact of the amortization of note receivable discount related to

1

The following information was filed by Accelrys, Inc. (ACCL) on Wednesday, October 31, 2012 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Accelrys, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Accelrys, Inc..

Continue

Assess how Accelrys, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Accelrys, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2012 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ACCL
CIK: 1002388
Form Type: 10-Q Quarterly Report
Accession Number: 0001002388-12-000007
Submitted to the SEC: Wed Oct 31 2012 7:42:44 PM EST
Accepted by the SEC: Thu Nov 01 2012
Period: Sunday, September 30, 2012
Industry: Prepackaged Software

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/accl/0001002388-12-000007.htm